Finance

Beta
Ask
Lists
531146:BOM
Medicamen Biotech Ltd
₹229.50
+2.34%
(+5.25) 1D
Jun 19, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 531146...
Open
₹225.50
High
₹230.10
Low
₹224.10
Mkt. cap
3.11B
Avg. vol.
2.22K
Volume
1.52K
P/E ratio
31.79
52-wk high
₹454.00
52-wk low
₹217.65
EPS
₹7.22
Shares outstanding
11.70M
No. of employees
376
Open
₹225.50
High
₹230.10
Low
₹224.10
Mkt. cap
3.11B
Avg. vol.
2.22K
Volume
1.52K
P/E ratio
31.79
52-wk high
₹454.00
52-wk low
₹217.65
EPS
₹7.22
Shares outstanding
11.70M
No. of employees
376
News stories
From sources across the web
About Medicamen Biotech Ltd
CEO-
Employees376
Founded1993
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
435.15M
475.43M
474.43M
623.82M
Cost of goods sold
227.13M
231.53M
237.10M
321.96M
Cost of revenue
227.13M
231.53M
237.10M
321.96M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
80.90M
88.31M
83.73M
93.99M
Operating expense
175.18M
207.18M
206.51M
247.43M
Total operating expenses
402.31M
438.71M
443.61M
569.39M
Operating income
32.84M
36.72M
30.83M
54.43M
Other non operating income
-
-
1.00K
-1.00K
EBT including unusual items
21.31M
26.83M
21.11M
50.60M
EBT excluding unusual items
21.31M
26.83M
21.11M
50.60M
Income tax expense
5.30M
5.69M
4.76M
6.13M
Effective tax rate
24.89%
21.19%
22.56%
12.11%
Other operating expenses
76.26M
100.30M
104.51M
136.10M
Net income
21.53M
26.67M
21.87M
38.57M
Net profit margin
4.95%
5.61%
4.61%
6.18%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-11.53M
-9.89M
-9.72M
-3.83M
Net interest expenses
-11.53M
-9.89M
-9.72M
-3.83M
Depreciation and amortization charges
18.01M
18.57M
18.27M
17.33M
EBITDA
50.53M
55.01M
48.10M
72.47M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more